The rapidly growing biotech ecosystem supporting innovation in Texas received national attention during a visit by BIO on Sept. 15-16.| Bio.News
Riboway Therapeutics, 2025 BIO Start-Up Stadium winner, decodes hidden RNA events to enable drugging targets once thought impossible.| Bio.News
BIO's 2025 report on the state of emerging biotechs finds that the landscape is challenging, though opportunities exist.| Bio.News
New political uncertainty could pose challenges for a slowly improving biotech M&A market, said panelists at BIO CEO 2025.| Bio.News
The idea of AI supercharging drug development is stirring a lot of excitement. However, a realistic understanding of what AI can and can’t do […]| Bio.News